Phase II trial of the multi-targeted antifolate LY231514 (MTA) as first-line therapy for patients with advanced non-small cell lung cancer (NSCLC) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Rusthoven, James
  • Eisenhauer, E
  • Butts, C
  • Gregg, R
  • Dancey, J
  • Fisher, B
  • Iglesias, J

publication date

  • September 1, 1997